STOCK TITAN

UL Solutions SEC Filings

ULS NYSE

Welcome to our dedicated page for UL Solutions SEC filings (Ticker: ULS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Decoding UL Solutions’ filings can feel like running a safety test on a 300-page document. The company’s 10-K weaves together industrial and consumer TIC revenue, software subscription growth, and laboratory capital expenses—dense topics that hide crucial red-flags and opportunities. If finding the exact number of global testing facilities or pinpointing warranty liability details slows you down, you’re not alone.

Stock Titan turns those hurdles into a three-click process. Our AI models translate every UL Solutions annual report 10-K simplified, flag changes in segment margins inside each UL Solutions quarterly earnings report 10-Q filing, and push UL Solutions Form 4 insider transactions real-time to your dashboard. Need the short version? We generate plain-English summaries so you can focus on decisions, not page counts. All documents flow in from EDGAR the moment they post, ensuring nothing is missed—even the midnight UL Solutions 8-K material events explained.

  • Track UL Solutions insider trading Form 4 transactions for patterns in executive stock movements.
  • Dive into UL Solutions proxy statement executive compensation to compare pay against safety-performance metrics.
  • Review every amendment, from the latest S-8 to an 11-K, with understanding UL Solutions SEC documents with AI.

Whether you’re dissecting revenue from calibration software or monitoring accreditation-related risk disclosures, our platform delivers the UL Solutions earnings report filing analysis professionals need. Real-time alerts, AI-powered summaries, and expert notes mean you spend less time searching and more time acting on reliable intelligence.

Rhea-AI Summary

Insider equity accruals and award aggregation reported by UL Solutions Inc. executive. Scott D'Angelo, EVP, CLO & Corporate Secretary, was credited with dividend equivalent rights that have been aggregated with underlying restricted stock units (RSUs) and reported together with the RSU awards. On 06/09/2025 the filing records acquisitions of 15 and 6 Class A common stock equivalents, increasing reported holdings to 8,578 and 3,574 shares respectively. On 09/08/2025 additional accruals of 17 and 7 were recorded, with resulting holdings of 8,595 and 3,581. The accrued dividend equivalents vest proportionately with the RSUs, which vest in three equal installments on the first, second and third anniversaries of May 1, 2025. The filing aggregates dividend equivalents with the underlying RSUs going forward.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Sally Susman, a director of UL Solutions Inc. (ULS), acquired dividend-equivalent rights tied to deferred restricted stock units that convert into Class A common stock. The Form 4 reports accruals of 10 and 5 dividend-equivalent rights on two separate sets of deferred restricted stock units, each settled for Class A common stock at no cash price. After these accruals, the reporting person beneficially owns 4,946 and 2,797 shares attributable to those deferred units and accrued dividend equivalents. The deferred units vest or were vested consistent with the issuer's director deferred compensation plan and are expected to be settled in shares per the plan's timing and election provisions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Vikram Kini, a director of UL Solutions Inc. (ULS), reported a Form 4 disclosing an acquisition of dividend-equivalent rights tied to restricted stock units on 09/08/2025. The filing shows 5 dividend equivalent rights were credited, each representing a contingent right to one share of Class A common stock, at a reported price of $0. After this accrual the reporting person beneficially owns 2,797 shares (including restricted stock units and accrued dividend equivalents). The underlying restricted stock units vest pro rata and will vest on the earlier of May 20, 2026 or the date of the issuer's next annual meeting. The Form 4 was signed by an attorney-in-fact on 09/10/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Marla C. Gottschalk, a director of UL Solutions Inc. (ULS), reported acquisitions on 09/08/2025 related to dividend equivalent rights on deferred restricted stock units (RSUs). The Form 4 shows accruals of 10 and 5 dividend-equivalent rights, each representing a contingent right to one share of the issuer's Class A Common Stock, recorded as acquisitions at $0. After the transactions the reporting person beneficially owned 4,946 and 2,797 shares attributable to those deferred RSUs respectively, held in direct form.

The filing explains the 10 rights relate to deferred RSUs that vested on May 1, 2025 and are expected to be settled in shares under the Non-Employee Director Deferred Compensation Plan, while the 5 rights vest on the earlier of May 20, 2026 or the next annual meeting and will be settled per the Plan.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Michael H. Thaman, a director of UL Solutions Inc. (ULS), received dividend equivalent rights accrued on restricted stock units. The reported transaction shows 5 dividend equivalent rights were credited, each representing a contingent right to one share of Class A Common Stock, at no cash price. After this accrual, the reporting person beneficially owns 2,797 shares (direct ownership). The accrued dividend equivalents vest on the same schedule as the related restricted stock units, which vest on the earlier of May 20, 2026 or the date of the next annual meeting.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Hooper Charles W, a director of UL Solutions Inc. (ULS), reported dividend-equivalent accruals tied to deferred restricted stock units on 09/08/2025. Two entries show accruals of dividend-equivalent rights that convert one-for-one into Class A common shares: an accrual of rights equal to 10 underlying shares (price $0) leaving 4,946 shares beneficially owned after the transaction, and an accrual equal to 5 underlying shares (price $0) leaving 2,797 shares beneficially owned after the transaction. The filing notes the first set of deferred RSUs vested on May 1, 2025 and will be settled in shares per the Non-Employee Director Deferred Compensation Plan; the second set vests on the earlier of May 20, 2026 or the next annual meeting and will likewise be settled in shares under the Plan. The Form 4 was signed by an attorney-in-fact on 09/10/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

UL Solutions Inc. insider Form 4 summary: Director George A. Williams reported the accrual and receipt of dividend-equivalent rights tied to deferred restricted stock units. On 09/08/2025 he was credited with 10 dividend-equivalent rights related to vested deferred restricted stock units and 5 dividend-equivalent rights on additional deferred restricted stock units that continue to vest. The accruals have $0 transaction price and increase his reported beneficial holdings to 4,946 and 2,797 Class A common stock-equivalent units, respectively. The deferred units are expected to be settled in shares under the company's non-employee director deferred compensation plan.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Kevin Kennedy, a director of UL Solutions Inc. (ULS), reported on Form 4 that on 09/08/2025 dividend equivalent rights accrued on deferred restricted stock units were recorded as acquisitions. The filing shows two accrual transactions for dividend equivalents: 10 shares and 5 shares, both at a $0 price, representing contingent rights to receive Class A Common Stock. The entries indicate those dividend equivalent rights vest in line with the underlying deferred restricted stock units and are expected to be settled in shares under the company’s Non-Employee Director Deferred Compensation Plan. The report lists beneficial ownership figures following the transactions of 4,946 and 2,797 shares respectively, held directly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

James P. Dollive, a director of UL Solutions Inc. (ULS), reported an equity grant accrual on 09/08/2025 that increased his beneficial ownership. The filing shows the accrual of 5 dividend equivalent rights tied to restricted stock units, each right representing one share of Class A common stock, recorded at a $0 price. After the reported accrual, the reporting person beneficially owned 2,797 shares (including outstanding restricted stock units and accrued dividend equivalents). The restricted stock units (and their dividend equivalents) vest on the earlier of May 20, 2026 or the date of the annual meeting following the grant. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person on 09/10/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Shannon James M, a director of UL Solutions Inc. (ULS), reported acquisition of dividend equivalent rights tied to deferred restricted stock units on 09/08/2025. The filing shows two accruals: one crediting 10 dividend equivalents (reflecting underlying Class A common stock) and another crediting 5 dividend equivalents, each recorded at a price of $0. After these accruals the reporting person beneficially owns 4,946 and 2,797 shares attributable to the related deferred restricted stock units and accrued dividend equivalents. The filing explains vesting and expected settlement mechanics: one set vested on May 1, 2025 and is eligible for settlement per the Non-Employee Director Deferred Compensation Plan; the other vests the earlier of May 20, 2026 or the annual meeting and is similarly expected to be settled in shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

What is the current stock price of UL Solutions (ULS)?

The current stock price of UL Solutions (ULS) is $66.75 as of September 12, 2025.

What is the market cap of UL Solutions (ULS)?

The market cap of UL Solutions (ULS) is approximately 13.1B.
UL Solutions

NYSE:ULS

ULS Rankings

ULS Stock Data

13.14B
61.90M
1.33%
109.13%
1.69%
Specialty Business Services
Services-testing Laboratories
Link
United States
NORTHBROOK